PATENT CLAIM ANALYSIS

Application Number: 16085861
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "04400R"]

Abstract:
It relates to a ribonucleic acid aptamer having an inhibitory effect on non-small cell lung cancer and a pharmaceutical composition comprising the same. The ribonucleic acid aptamer can bind to human non-small cell lung cancer in vivo or in vitro with high specificity and high affinity to achieve an effect of inhibiting non-small cell lung cancer; and the ribonucleic acid aptamer can also be linked, coupled or polymerized with other non-small cell lung cancer therapeutic drugs to achieve a more excellent effect of inhibiting non-small cell lung cancer.

Claim (Index 1):
A pharmaceutical composition comprising a ribonucleic acid aptamer, characterized in that the pharmaceutical composition comprises a ribonucleic acid aptamer and a pharmaceutically acceptable carrier,\n wherein, the nucleic acid aptamer is selected from:\n (1) a ribonucleic acid aptamer having a nucleotide sequence as shown in SEQ ID NO: 1; or \n (2) a ribonucleic acid aptamer capable of hybridizing with a nucleotide sequence shown in SEQ ID NO: 1 under stringent conditions and having a function of specifically binding to human non-small cell lung cancer cells; or \n (3) a ribonucleic acid aptamer having 80% or more identity with the nucleotide sequence shown in SEQ ID NO: 1 and having a function of specifically binding to human non-small cell lung cancer cells; or \n (4) a ribonucleic acid aptamer being a truncation of the nucleotide sequence shown in SEQ ID NO: 1 and having a function of specifically binding to human non-small cell lung cancer cells; or \n (5) a ribonucleic acid aptamer having a nucleotide sequence complementary to a nucleotide sequence of the ribonucleic acid aptamer defined by any one of (1) to (4).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.84
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15755958', '14411176', '15500345', '13876111', '15500354']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7684180739118976
- 35 USC 102 Novelty (BERT): 0.5172136735376472
- Combined Prediction Score: 0.7432976338744727
- Mean Citation Score: 274.036032
- Max Citation Score: 299.6154
- Similarity Product: 197.8808068591833

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test